Since MSL cells predominate in CLBC and constitute a minority population in BLBC, we determined whether tumor cell lines classified as CL/TNB or BL/TNA are sensitive to CHK1 inhibitors. The gene discussed is CHEK1; the disease is Burkitt lymphoma.